Literature DB >> 29700818

Angiosarcoma of the scalp responding to nivolumab: a case report.

S Hofer1, K Zeidler1, A Schipf2, W Kempf3,4, D Zimmermann5, S Aebi1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29700818     DOI： 10.1111/bjd.16698

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN： 0007-0963            Impact factor:   9.302


× No keyword cloud information.
  2 in total

1.  Clinical implications of systemic and local immune responses in human angiosarcoma.

Authors:  Jason Yongsheng Chan; Grace Fangmin Tan; Joe Yeong; Chee Wee Ong; Dave Yong Xiang Ng; Elizabeth Lee; Joanna Koh; Cedric Chuan-Young Ng; Jing Yi Lee; Wei Liu; Ru Xin Wong; Chin-Ann Johnny Ong; Mohamad Farid; Bin Tean Teh; Khee Chee Soo
Journal:  NPJ Precis Oncol       Date:  2021-02-12

2.  Multicenter phase II trial (SWOG S1609, cohort 51) of ipilimumab and nivolumab in metastatic or unresectable angiosarcoma: a substudy of dual anti-CTLA-4 and anti-PD-1 blockade in rare tumors (DART).

Authors:  Michael J Wagner; Megan Othus; Sandip P Patel; Chris Ryan; Ashish Sangal; Benjamin Powers; G Thomas Budd; Adrienne I Victor; Chung-Tsen Hsueh; Rashmi Chugh; Suresh Nair; Kirsten M Leu; Mark Agulnik; Elad Sharon; Edward Mayerson; Melissa Plets; Charles Blanke; Howard Streicher; Young Kwang Chae; Razelle Kurzrock
Journal:  J Immunother Cancer       Date:  2021-08       Impact factor: 13.751
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.